Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

Discover advanced imaging methods revealing significant insights about the tumour microenvironment and cancer treatment improvements.

The body has to clear away dead cells and other unnecessary or unneeded stuff, and one mechanism that is crucial to the ...

Discover why Janux Therapeutics, Inc.'s promising immunotherapy data and strong cash position draw attention—plus key risks.

Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

A research team of Lee Je-joong and Jung Sung-hoon and Dr. Lee Min-geun of the Department of Hematology at Hwasun Chonnam ...